BFA
LUMO

BlackRock Fund Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

BlackRock Fund Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$11.5M Buy
124,163
+14,156
+13% +$1.6M ﹤0.01% 2496
2016
Q3 		$14.9M Buy
110,007
+6,314
+6% +$627K ﹤0.01% 2235
2016
Q2 		$10.5M Sell
103,693
-28,075
-21% -$3.48M ﹤0.01% 2385
2016
Q1 		$21.6M Buy
131,768
+10,313
+8% +$2.09M 0.01% 1946
2015
Q4 		$39.8M Sell
121,455
-2,957
-2% -$963K 0.01% 1633
2015
Q3 		$40.1M Buy
124,412
+5,385
+5% +$2.37M 0.01% 1562
2015
Q2 		$47.4M Sell
119,027
-9,542
-7% -$4.05M 0.01% 1562
2015
Q1 		$63.3M Buy
128,569
+2,427
+2% +$940K 0.02% 1344
2014
Q4 		$45.1M Buy
126,142
+8,594
+7% +$2.56M 0.01% 1531
2014
Q3 		$22.7M Buy
117,548
+1,925
+2% +$423K 0.01% 1877
2014
Q2 		$27.6M Buy
115,623
+4,599
+4% +$935K 0.01% 1813
2014
Q1 		$28.4M Buy
111,024
+27,036
+32% +$8.27M 0.01% 1802
2013
Q4 		$16.6M Sell
83,988
-102
-0.1% -$18.1K 0.01% 2091
2013
Q3 		$14.2M Buy
84,090
+11,018
+15% +$1.77M ﹤0.01% 2152
2013
Q2 		$13M Buy
+73,072
New +$10.3M ﹤0.01% 2109

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

BlackRock Fund Advisors's LUMO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Lumos Pharma, Inc. Common Stock (LUMO) stake by 13% in Q4 2016, buying an estimated $1.6M and bringing the position to 124,163 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

BlackRock Fund Advisors first reported a position in LUMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $63.3M in Q1 2015. 122 funds tracked by Wall St. Rank hold LUMO as of Q4 2016.

  • BlackRock Fund Advisors held 124,163 shares of Lumos Pharma, Inc. Common Stock worth $11.5M as of Q4 2016.
  • BlackRock Fund Advisors bought 14,156 Lumos Pharma, Inc. Common Stock shares in Q4 2016, an estimated $1.6M.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2496 holding.
  • BlackRock Fund Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Lumos Pharma, Inc. Common Stock position peaked at $63.3M in Q1 2015.
  • 122 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.